Healthcare
1090 companies in this sector
Insider Buys (30d)
74
$46.51M
Insider Sells (30d)
483
$1.39B
Monthly Insider Volume
Industries
Biotechnology615 companies
Medical - Devices130 companies
Drug Manufacturers - Specialty & Generic66 companies
Medical - Diagnostics & Research52 companies
Medical - Instruments & Supplies51 companies
Medical - Care Facilities46 companies
Medical - Healthcare Information Services45 companies
Medical - Pharmaceuticals22 companies
Drug Manufacturers - General22 companies
Medical - Healthcare Plans13 companies
Medical - Distribution11 companies
Medical - Equipment & Services11 companies
Medical - Specialties6 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Buy | 2,200 | $13.43 | $29.6K |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | officer: President, R&D | Sell | 2,237 | $18.61 | $41.6K |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | officer: Chief Financial Officer | Sell | 1,459 | $18.61 | $27.2K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | officer: Chief Scientific Officer | Sell | 3,847 | $23.38 | $90.0K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | van Houte Hans | officer: Chief Financial Officer | Sell | 2,845 | $23.38 | $66.5K |
| Jul 30, 2026 | ATRC | AtriCure, Inc. | WEHRWEIN SVEN | director | Sell | 25,000 | $37.84 | $946.0K |
| Jul 30, 2026 | ATRC | AtriCure, Inc. | Noznesky Justin J | officer: Chief Mktg & Strategy Officer | Sell | 6,182 | $38.80 | $239.9K |
| Jul 30, 2026 | TEM | Tempus AI, Inc. | LEFKOFSKY ERIC P | director, 10 percent owner, officer: CEO and Chairman | Sell | 250,000 | $42.06 | $10.51M |
| Jul 30, 2026 | EW | Edwards Lifesciences Corporation | Markowitz Wayne | officer: CVP, JAPAC | Sell | 146 | $86.03 | $12.6K |
| Jul 30, 2026 | CYTK | Cytokinetics, Incorporated | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 14,000 | $79.88 | $1.12M |
| Jul 30, 2026 | COSM | Cosmos Health Inc. | Siokas Grigorios | director, 10 percent owner, officer: Chief Executive Officer | Buy | 766,284 | $0.18 | $140.0K |
| Jul 30, 2026 | PFSA | Profusa, Inc. Common Stock | HRT FINANCIAL LP | 10 percent owner | Buy | 1,310 | $1.01 | $1.3K |
| Jul 30, 2026 | NBIX | Neurocrine Biosciences, Inc. | Norwalk Leslie V | director | Sell | 1,250 | $182.01 | $227.5K |
| Jul 30, 2026 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | officer: Chief Legal Officer | Sell | 3,847 | $23.38 | $90.0K |
| Jul 30, 2026 | ANIP | ANI Pharmaceuticals, Inc. | CAREY STEPHEN P. | officer: SVP & CFO | Sell | 2,850 | $81.36 | $231.9K |
| Jul 30, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $522.37 | $4.96M |
| Jul 30, 2026 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | officer: See remarks | Sell | 748 | $18.61 | $13.9K |
| Jul 30, 2026 | KPTI | Karyopharm Therapeutics Inc. | Poulton Stuart | officer: EVP, Chief Development Officer | Sell | 189 | $7.10 | $1.3K |
| Jul 30, 2026 | ATRC | AtriCure, Inc. | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 6,000 | $38.88 | $233.3K |
| Jul 29, 2026 | MEDP | Medpace Holdings, Inc. | Troendle August J. | director, 10 percent owner, officer: President & CEO | Sell | 7,238 | $600.44 | $4.35M |
| Jul 29, 2026 | DGX | Quest Diagnostics Incorporated | DELANEY MARK E | officer: SVP & Chief Commercial Officer | Sell | 1,600 | $235.18 | $376.3K |
| Jul 29, 2026 | ISRG | Intuitive Surgical, Inc. | Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 84 | $356.60 | $30.0K |
| Jul 29, 2026 | LQDA | Liquidia Corporation | Boyle Dana | officer: Chief Accounting Officer | Sell | 1,600 | $87.53 | $140.0K |
| Jul 29, 2026 | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10 percent owner | Buy | 17,608 | $4.98 | $87.7K |
| Jul 29, 2026 | ENSG | The Ensign Group, Inc. | Blouin Ann Scott | director | Sell | 375 | $183.54 | $68.8K |
| Jul 29, 2026 | NTRA | Natera, Inc. | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,713 | $257.00 | $440.2K |
| Jul 29, 2026 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | director | Buy | 95,398 | $1.05 | $100.0K |
| Jul 29, 2026 | BEAM | Beam Therapeutics Inc. | Simon Amy | officer: Chief Medical Officer | Sell | 16,667 | $25.74 | $429.0K |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | Mancini Marianna | officer: Chief Operating Officer | Sell | 18,217 | $33.47 | $609.6K |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | Lian Brian | director, officer: President & CEO | Sell | 148,517 | $33.32 | $4.95M |
| Jul 29, 2026 | AVTX | Avalo Therapeutics, Inc. | Doyle Mittie | officer: Chief Medical Officer | Sell | 1,000 | $20.00 | $20.0K |
| Jul 29, 2026 | NTRA | Natera, Inc. | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 479 | $257.93 | $123.5K |
| Jul 29, 2026 | NTRA | Natera, Inc. | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | Sell | 1,718 | $260.49 | $447.5K |
| Jul 29, 2026 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Buy | 1,500 | $13.62 | $20.4K |
| Jul 29, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $42.11 | $93.1K |
| Jul 29, 2026 | AVR | Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 10 percent owner | Sell | 441,548 | $8.14 | $3.60M |
| Jul 29, 2026 | DYN | Dyne Therapeutics, Inc. | Kersten Dirk | director | Sell | 261,460 | $25.51 | $6.67M |
| Jul 29, 2026 | VKTX | Viking Therapeutics, Inc. | ZANTE GREG | officer: Chief Financial Officer | Sell | 21,217 | $33.47 | $710.1K |
| Jul 29, 2026 | EDIT | Editas Medicine, Inc. | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $2.67 | $13.2K |
| Jul 29, 2026 | NTRA | Natera, Inc. | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,770 | $256.51 | $1.48M |
| Jul 29, 2026 | NTRA | Natera, Inc. | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,214 | $257.00 | $569.0K |
| Jul 29, 2026 | NTRA | Natera, Inc. | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $253.28 | $1.28M |
| Jul 29, 2026 | MEDP | Medpace Holdings, Inc. | BURWIG SUSAN E | officer: Exec. VP, Operations | Sell | 7,500 | $600.00 | $4.50M |
| Jul 29, 2026 | CSTL | Castle Biosciences, Inc. | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | Sell | 9,002 | $24.16 | $217.5K |
| Jul 29, 2026 | NTRA | Natera, Inc. | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,887 | $257.08 | $485.1K |
| Jul 29, 2026 | LQDA | Liquidia Corporation | Adair Jason | officer: Chief Business Officer | Sell | 688 | $87.53 | $60.2K |
| Jul 29, 2026 | BCDA | BioCardia, Inc. | Altman Peter | director, officer: President and CEO | Buy | 5,000 | $0.78 | $3.9K |
| Jul 28, 2026 | DRIO | DarioHealth Corp. | Matheis Dennis | director | Buy | 14,430 | $6.93 | $100.0K |
| Jul 28, 2026 | THC | Tenet Healthcare Corporation | Arbour Paola M | officer: EVP, Chief Information Officer | Sell | 10,878 | $243.90 | $2.65M |
| Jul 28, 2026 | THC | Tenet Healthcare Corporation | BIERMAN JAMES L | director | Sell | 5,000 | $244.96 | $1.22M |
Showing 1–50 of 500
1 / 10
...